Home
Notifica
Profilo
Articoli di tendenza
Notizie
Aggiunto ai segnalibri e ai mi piace
Centro creator
Impostazioni
Visualizza originale
LIVE
NEABGoC
--
Segui
$USUAL
Aspettando di acquistare al ribasso💃
#write2earn
Disclaimer: Include opinioni di terze parti. Non è una consulenza finanziaria. Può includere contenuti sponsorizzati.
Consulta i T&C.
USUAL
1,2583
-6.10%
1.4k
0
Risposte
0
Esplora le ultime notizie sulle crypto
⚡️ Partecipa alle ultime discussioni sulle crypto
💬 Interagisci con i tuoi creator preferiti
👍 Goditi i contenuti che ti interessano
Email / numero di telefono
Registrati
Accedi
Creator pertinente
LIVE
NEABGoC
@NEABGoC
Segui
Scopri di più dal Creator
#BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.The BIO token is the key the DeSci economy. It is a governance token that lets holders signal support for specific BioDAOs and gain whitelisted access to their initial funding rounds. #MarketRebound
--
#BinanceLaunchpoolBIO How much #bnb or #FDUSD have you locked? #MarketRebound
--
How much #BNB or #FDUSD did you lock to mine #BIO Let's get interactive. #MarketRebound
--
It's about to go down, I have locked a few BNB and FDUSD. #write2earn $usdt $Fdusd
--
$USUAL Have you withdrawn already or you are still holding? Are you in regret or happy? #write2earn
--
Ultime notizie
AiPool Warns Of Potential Wallet Drainer Risk
--
Solana Surpasses 200 USDT With Significant 24-Hour Gain
--
Bitcoin(BTC) Drops Below 98,000 USDT with a Narrowed 4.02% Increase in 24 Hours
--
South African MP Advocates Bitcoin Adoption to Hedge Gold Reserves
--
Bitcoin And Altcoins Show Recovery As Wallet Accumulation Continues
--
Vedi altro
Mappa del sito
Cookie Preferences
T&C della piattaforma